Brief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
04/09/2024 12:30
Sept 4 (Reuters) -
* GALERA THERAPEUTICS-ON AUG 31, WAS NOTIFIED THAT NASDAQ
WILL
DELIST CO'S COMMON STOCK BY FILING FORM 25 WITH SEC ON SEPT 4
* GALERA THERAPEUTICS - DELISTING IS EXPECTED TO BECOME
EFFECTIVE
TEN DAYS AFTER FILING OF FORM 25
Source text for Eikon: ID:n0001193125-24-212627
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement